共 2 条
- [2] Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2459 - 2464